1 / 9

Middle East Respiratory Syndrome Coronavirus (MERS- CoV ) Update

Middle East Respiratory Syndrome Coronavirus (MERS- CoV ) Update. April 29, 2014. Major Increase in MERS CoV. *Source: ECDC. 163 new cases since April 2014* At least 43 are reported to be HCWs Cluster in UAE involving 16 HCWs/paramedics Case Counts* 133 cases in KSA 25 in UAE

nhung
Télécharger la présentation

Middle East Respiratory Syndrome Coronavirus (MERS- CoV ) Update

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Update April 29, 2014

  2. Major Increase in MERS CoV *Source: ECDC • 163 new cases since April 2014* • At least 43 are reported to be HCWs • Cluster in UAE involving 16 HCWs/paramedics • Case Counts* • 133 cases in KSA • 25 in UAE • 2 in Jordan • 1 in each (Greece, Malaysia, Philippines)

  3. Additional Information • 75% of cases due to secondary spread (source: WHO) • Total of 345 cases, 107 deaths (as of 4/25) (Source: ECDC) • Reason for increase still unclear • Seasonality? • Nosocomial transmission? • Better case detection? • Changes in virus?

  4. Requests for Testing • Form on THAN • https://home.tnhan.tn.gov/default.aspx • Requires approval by Central Office • Marion Kainer, Tim Jones, John Dunn, Kelly Moore • Specimen submission guidelines on back of form • Coordinate with state lab

  5. MERS Testing • Preferred specimens: • Broncheoalveolar lavage, tracheal aspirate, pleural fluid or sputum • Other specimens: • Nasopharyngeal swabs, oropharyngeal swabs • State lab can perform PCR

  6. Person Under Investigation (PUI) • http://www.cdc.gov/coronavirus/mers/case-def.html • Acute respiratory infection (fever, cough) AND suspicion of pulmonary parenchymal disease (e.g. ARDS, pneumonia) • AND (one of the following) • History of travel to affected area within 14 days • Close contact with symptomatic traveler who developed fever and acute respiratory illness within 14 days of travel • Member of a cluster of patients with severe acute resp. illness • Clusters of SARI • HCW who have cared for patients with SARI

  7. Questions marion.kainer@tn.gov

More Related